APA aipamena

Sherman, A. C., Trehanpati, N., Daucher, M., Davey, R. T., Masur, H., Sarin, S. K., . . . Kohli, A. (2013). Augmentation of Hepatitis B Virus-Specific Cellular Immunity with Programmed Death Receptor-1/Programmed Death Receptor-L1 Blockade in Hepatitis B Virus and HIV/Hepatitis B Virus Coinfected Patients Treated with Adefovir. Mary Ann Liebert, Inc.

Chicago Style aipamena

Sherman, Amy C., Nirupama Trehanpati, Marybeth Daucher, Richard T. Davey, Henry Masur, Shiv Kumar Sarin, Shyam Kottilil, and Anita Kohli. Augmentation of Hepatitis B Virus-Specific Cellular Immunity With Programmed Death Receptor-1/Programmed Death Receptor-L1 Blockade in Hepatitis B Virus and HIV/Hepatitis B Virus Coinfected Patients Treated With Adefovir. Mary Ann Liebert, Inc, 2013.

MLA aipamena

Sherman, Amy C., et al. Augmentation of Hepatitis B Virus-Specific Cellular Immunity With Programmed Death Receptor-1/Programmed Death Receptor-L1 Blockade in Hepatitis B Virus and HIV/Hepatitis B Virus Coinfected Patients Treated With Adefovir. Mary Ann Liebert, Inc, 2013.